000 01220 a2200301 4500
005 20250513084336.0
264 0 _c19960223
008 199602s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1996.14.1.322
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPerez, E A
245 0 0 _aSchedule-dependent edatrexate toxicity.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 1996
300 _a322-3 p.
_bdigital
500 _aPublication Type: Comment; Comparative Study; Letter
650 0 4 _aAminopterin
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aMouth Mucosa
650 0 4 _aPalliative Care
650 0 4 _aStomatitis
_xprevention & control
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 14
_gno. 1
_gp. 322-3
856 4 0 _uhttps://doi.org/10.1200/JCO.1996.14.1.322
_zAvailable from publisher's website
999 _c8557289
_d8557289